Stay updated on MCS110/BRAF/MEK Inhibition in Melanoma Clinical Trial
Sign up to get notified when there's something new on the MCS110/BRAF/MEK Inhibition in Melanoma Clinical Trial page.

Latest updates to the MCS110/BRAF/MEK Inhibition in Melanoma Clinical Trial page
- Check6 days agoChange DetectedA new Revision: v3.4.3 was added to the record history, and the previous Revision: v3.4.2 entry was removed.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2; removed the previous funding/operating-status notice (Revision: v3.4.1).SummaryDifference0.7%

- Check42 days agoChange DetectedAdded a site-wide funding-status notice and updated the release version from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check49 days agoChange DetectedThe changes are UI-related: a 'Show glossary' option was added, color-coded indicators for changes were explained, and the latest Revision: v3.4.0 was introduced while the prior Revision: v3.3.4 label and the 'No FEAR Act Data' item were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1.0%

- Check63 days agoChange DetectedThe page history now includes a new Revision: v3.3.4, and the previous Revision: v3.3.3 has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedFooter updates show Revision: v3.3.3; the HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to MCS110/BRAF/MEK Inhibition in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MCS110/BRAF/MEK Inhibition in Melanoma Clinical Trial page.